MATERNAL PREVALENCE OF TOXOPLASMA ANTIBODY BASED ON ANONYMOUS NEONATAL SEROSURVEY - A GEOGRAPHICAL ANALYSIS by ADES, AE et al.
Epidemiology and Infection
http://journals.cambridge.org/HYG
Additional services for Epidemiology and Infection:
Email alerts: Click here
Subscriptions: Click here
Commercial reprints: Click here
Terms of use : Click here
Maternal prevalence of toxoplasma antibody based 
on anonymous neonatal serosurvey: a geographical 
analysis
A. E. Ades, S. Parker, R. Gilbert, P. A. Tookey, T. Berry, M. Hjelm, A. H. Wilcox, D. Cubitt 
and C. S. Peckham
Epidemiology and Infection / Volume 110 / Issue 01 / February 1993, pp 127 ­ 133
DOI: 10.1017/S0950268800050755, Published online: 15 May 2009
Link to this article: http://journals.cambridge.org/abstract_S0950268800050755
How to cite this article:
A. E. Ades, S. Parker, R. Gilbert, P. A. Tookey, T. Berry, M. Hjelm, A. H. Wilcox, D. Cubitt 
and C. S. Peckham (1993). Maternal prevalence of toxoplasma antibody based on 
anonymous neonatal serosurvey: a geographical analysis. Epidemiology and 
Infection,110, pp 127­133 doi:10.1017/S0950268800050755
Request Permissions : Click here
Downloaded from http://journals.cambridge.org/HYG, IP address: 144.82.107.22 on 13 Sep 2012
Epidemiol. Infect. (1993). 110. 127-133 1 2 7
Copyright © 1993 Cambridge University Press
Maternal prevalence of toxoplasma antibody based on anonymous
neonatal serosurvey: a geographical analysis
A. E. ADES1*, S. PARKER1, R. GILBERT1, P. A. TOOKEY1, T. BERRY1.
M. HJELM\ A. H. WILCOX2, D. CUBITT1 AND C. S. PECKHAM1
1
 Epidemiology and Biostatistics Unit, Department of Virology, and Department of
Clinical Biochemistry, Institute of Child Health and Hospitals for Sick Children
2
 Neonatal Screening Laboratory, St Helier Hospital, Carshalton
(Accepted 14 September 1992)
SUMMARY
A total of 12902 neonatal samples collected on absorbent paper for routine
metabolic screening were tested anonymously for antibodies to toxoplasma.
Seroprevalence varied from 19-5% in inner London, to 11-6% in suburban
London, and 7-6% in non-metropolitan districts. Much of this variation appeared
to be associated with the proportions of livebirths in each district to women born
outside the UK. However, additional geographical variation remained and
seroprevalence in UK-born women was estimated to be 12-7% in inner London,
7-5% in suburban London, and 5'5% in non-metropolitan areas. These estimates
are considerably lower than any previously reported in antenatal sera in the UK.
The wide geographical variation highlights a need for further research to
determine the relative importance of different routes of transmission.
INTRODUCTION
Toxoplasma gondii is a protozoan parasite transmitted to humans either as
oocysts via soil contaminated with cat faeces, or from tissue cysts in undercooked
meats [1]. Infection is thought to pose few problems for the immune-competent,
though a primary infection in pregnancy may lead to fetal infection. Congenital
infection may result in severe disease presenting at or shortly after birth, but an
unknown proportion of those without perinatal manifestations may go on to
develop retinochoroiditis, sometimes leading to unilateral or bilateral visual
impairment. Seroprevalence in women of childbearing age varies widely. In a 1985
survey of antenatal samples in four European cities prevalence varied from 21 %
in inner London to 72% in Paris, with Stuttgart 36% and Padua 56% [1]. In the
United Kingdom estimates based on antenatal sera during the last 20 years have
ranged from 22 to 13% [2].
The present study was undertaken initially to evaluate methods for detecting
antibodies to toxoplasma in blood samples routinely collected on absorbent paper
(Guthrie Cards) for neonatal metabolic screening [3]. The presence of antibody in
neonatal samples reflects previous maternal exposure, and this promised to be a
* Correspondence and reprint requests to: Dr A. E. Ades. Epidemiology and Biostatistics
Unit. Institute of Child Health. 30 Guilford Street. London WC1N.
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simple and inexpensive method of mass serosurvey. In the course of the study,
marked differences in seroprevalence emerged between inner city, suburban, and
non-metropolitan districts. These differences form the subject of this paper.
METHODS
After routine neonatal metabolic tests had been completed, 5-5 mm diameter
dried blood spots (DBS) were punched out of Guthrie cards received at two
neonatal screening laboratories serving XE, XW, and SW Thames Health
Regions. The area covered in the study comprises three quarters of south eastern
England, including inner London, suburban London, and non-metropolitan
districts. The only information retained with each DBS was the Health District of
the midwife collecting the sample, which is usually the mother's Health District.
A Health District is an administrative unit of the Xational Health Service, and 42
were included in the study. A total of 12902 samples were collected over a 5-week
period in mid 1991. Serum was eluted from the samples [3] and eluates were tested
for toxoplasma-specific antibody using a modified latex-agglutination method.
This test was developed using simulated DBS samples made from sera of known
titre. Based on 103 negative and 170 positive samples specificity was 100% and
sensitivity 98'8%, with two false negative DBS samples deriving from equivocal
sera [4]. Development work established that the dilution of maternal toxoplasma-
specific antibody in the 5-10 day-old neonate was slight, and that there was a clear
distinction between positive and negative eluates when they were titrated to
endpoints [4].
In order to interpret the geographic variation observed, we employed results
from an unpublished study of toxoplasma seroprevalence. This was based on
unselected, consecutive antenatal samples collected 1981-6 in an inner London
clinic [5], which were tested for specific IgG by enzyme immunoassay (Captia
Toxo IgG, Mercia Diagnostics). Titres greater or equal to 12 IU per ml were taken
as positive, and on this criteria the test was 99-1 % sensitive and 100% specific
when assessed against a 'gold standard' developed for 1000 samples from tests on
5 separate commercial assays [6]. In that study, seroprevalence in UK-born
women was 13-3%: differences between black and white UK-born women were
negligible. Antenatal seroprevalence in women born overseas varied from 7-6% in
women from India to over 40% in women born in parts of Africa. In the present
study eight ethnic/country of birth groups were defined, and their antenatal
seroprevalences used in the geographical analysis of District seroprevalence.
Data on the numbers of births in each district broken down by mothers' country
of birth for the year 1990 were obtained from the Office of Population Censuses
and Surveys (OPCS). The seroprevalence expected in each district i, E{, was then
calculated using the proportions Ptj of births in district i to mothers in groupj, and
the group seroprevalences s;- given in Table 1:
This gives the district seroprevalence as a weighted average of the ethnic group
seroprevalences, with the ptj as weights, and represents the predicted district
seroprevalence assuming that its ethnic/country of birth composition is the only
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relevant explanatory factor. In order to examine the additional role of other
demographic factors, the number of seropositives, rt, out of the total tested, nt, in
each district was treated as the outcome variable in binomial multiple regression
for risk differences [7]. The proportion Et expected on the basis of country of birth,
was included in every regression model:
fen, k=l...C
to estimate regression coefficients /? for C additional explanatory variables z after
the district of birth composition had been taken into account. Models of this form
assume a linear relation between district seroprevalence and the explanatory
variables. The additional variables of interest were: the 1981 district population
density, the Jarman Underprivileged Area Score, a weighted average of census
variables reflecting social deprivation, and indicator variables for inner London,
suburban, and non-metropolitan districts.
The goodness of fit of binomial regression models is assessed by its log-likelihood
X2 residual deviance. The smaller the deviance the better the fit; and in a good
fitting model the residual deviance should approximately equal the residual
degrees of freedom.
RESULTS
Table 1 summarises the antenatal toxoplasmosis seroprevalence from the earlier
study, used to define the s} of equation (1). There is marked variation depending
on country of birth, ranging from 7-6% in women born in India and 15'3% in
women from East Africa who are nearly all of Asian ethnic origin, up to 33-l % in
Caribbeans and over 40% in women born in the rest of Africa. Also in Table 1 is
a summary breakdown of the mothers' country of birth in 1990, based on OPCS
figures. In inner London only 54-8% of deliveries are to UK-born women,
compared to 90'3% in non-metropolitan districts. While Table 1 gives the
percentage distribution within inner, suburban, and non-metropolitan areas, it is
the percentage distribution within each of the 42 health districts that was used to
define the p^ used in equation (1).
The neonatal toxoplasmosis seroprevalence findings are presented in Table 2.
Results from the 42 health districts have been pooled together in three classes of
district. Seroprevalence in inner London is considerably higher (19-5%) than in
non-metropolitan districts (7*5%), with suburban districts intermediate (11-7%).
The neonatal seroprevalence expected on the basis of ethnic/country of birth
composition is shown under Expected Seroprevalence model 1. The prediction for
Inner London is close (19'6%). However, in suburban and non-metropolitan
districts the seroprevalence is overestimated, with high x2 deviance evidencing a
poor fit.
The seroprevalence assumed in UK-born women was 13-3% (Table 1), based on
the earlier study which was set in inner London, much higher than the overall
neonatal seroprevalence in suburban and non-metropolitan districts. The failure
to predict seroprevalence in these areas could therefore be due to geographical
variation in seroprevalence among UK-born women.
Accordingly model 2 was fitted, which took account of the ethnic/country of
birth variation, and which also allowed seroprevalence in UK-born women to be
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Table 1. Toxoplasmosis seroprevalence (Captia Toxo-G. Mercia Diagnostics) in
antenatal sera collected from an inner London antenatal clinic (unpublished study);
and percent livebirths to women born in eight country of birth groups, based on 1990
data from the Office of Population Censuses and Surveys
United Kingdom
India
Xew Commonwealth East Africa*
Rest of Africat
Pakistan & Bangladesh
Republic of Ireland
Caribbean
Rest of world
Antenatal
toxoplasmosis
seroprevalence
in Inner London
(Xumber
% tested)
13-3 (3769)
7-6 (317)
15-3 (288)
40-5 (172)
21-7 (170)
311 (412)
33-1 (320)
26-8 (959)
Percentage of 1990
Inner
London
54-8
3-3
2-8
6-5
9-6
3-7
2-9
16-4
Suburban
London
741
4 0
3-7
1-8
2-7
2-7
1-5
9-5
deliveries in
Xon-
metropolitan
90-3
0-6
1-0
0-3
1-7
10
0-4
4-7
* Xew Commonwealth (XCW) East Africa includes Kenya, Uganda. Tanzania, Zambia and
Malawi. It was assumed that all women born in Xew Commonwealth (XCW) East Africa were
Asian.
t It was assumed that 15% of those born in the rest of Africa were white [12J and that their
toxoplasma seroprevalence was 10%.
Table 2. Observed and expected neonatal seroprevalence
Inner
London
Suburban
London
Xon-
metropolitan
Xumber of
districts
10
13
19
Observed
seroprevalence
Total
tested
3039
4282
5581
( /o
positive)
(19-5)
(11-8)
(7-5)
Expected*
seroprevalence, %
(X2 residual deviance)
A
Model Model
1 2
42 D.F. 39 D.F.
19-6 19-3
(7-0) (6-8)
16-2 117
(94-8) (21-3)
14-6 7-6
(296-8) (34-6)
Model
3
37 D.F.
19-5
(4-6)
118
(19-1)
7-6
(27-9)
* Model (1): based on seroprevalence data in Table 1 ; Model (2): from data in Table 1 but with
seroprevalence in UK-born women as shown in Table 3; Model (3): same as (2) but also
accounting for population density and Jarman Area Score.
dependent on type of borough. The results are shown in Table 3. The estimates of
seroprevalence in UK-born women are: 12-7 % in inner London. 7-1 % in suburban
and 5-5% in non-metropolitan districts. These figures, together with the
ethnic/country of birth distribution, can be used to generate expected district
seroprevalences. Although the district seroprevalence predicted by model 2 is
much closer to observed seroprevalence than model 1 (see Table 2), the overall fit
of model 2 was not close (x2 = 62-6 on 39 D.F. P < 0-025), particularly in non-
metropolitan areas.
After accounting for ethnic/country of birth composition, and for the
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Table 3. Estimated seroprevalences in UK-born women, taking account of the
ethnic/country of birth composition (Model 2)
Inner London
Suburban London
Non-metropolitan
Estimated
seroprevalence
12-7
71
5-5
95% confidence
interval
10-2-15-2
5-9- 8-4
4-8- 6-3
dependency of seroprevalence in UK-born women on type of district, both the
Jarman area scores (x\ = 10-9, P < 0-001) and the population density (x\ = 4"0,
P < 0-05) were independently statistically significant. In model 3, seroprevalence
was higher in districts with a higher Jarman score (more underprivileged), but
after controlling for Jarman score, was lower in districts with higher population
density. The improvement in fit is most marked in non-metropolitan districts. The
X2 of 51-6 on 37 D.F. is only a barely adequate fit. However, because of the
relatively small study sample, the proportions of overseas-born women in each
district could differ from the proportions expected on the basis of the 1990 OPCS
figures. This would generate additional random variation, over and above what
would be expected from the binomial error.
Models including terms for Jarman score, population density and proportions
UK-born in different types of borough, but which did not take account of the
ethnic/country of birth composition, fitted the data poorly (xl7 = 78-9). A model
which allowed for overall variation between types of District, not confined to UK-
born women, had residual deviance 3-8 x2 units higher than the model allowing for
variation in the UK-born alone. A model allowing for variation in non-UK-born
women, but not UK-born, had a deviance 28-8 higher. Once variation in the UK-
born was accounted for, variation in non-UK born was not statistically significant
(^ 3 = 2-0, P > 0-1). The assumption that the additional geographic variation
resided in UK-born women, while not conclusively proven, received the most
support from the data.
DISCUSSION
This study has demonstrated a more than twofold variation in neonatal
toxoplasmosis seroprevalence between inner city and rural districts in SE
England.
A limitation of using neonatal samples to conduct what is effectively a maternal
seroprevalence survey is that at present only limited information is retained with
each sample. A geographical analysis, explaining district seroprevalence in terms
of district attributes, was therefore the only one possible. However, we were able
to combine antenatal toxoplasmosis seroprevalence data for eight country of birth
groups with the district distribution of mothers' country of birth. The results
suggested that much of the variation between districts in neonatal seroprevalence
could be explained by their ethnic/country of birth composition.
In the antenatal study, based in an inner city antenatal clinic, the seroprevalence
in UK-born women was 13-3% (95%CI 12-2-14-4), and there was no dependency
on ethnic status. This finding, taking into account the higher seroprevalence in
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other immigrant groups, proved to be entirely compatible with the Inner London
aggregate seroprevalence of 19-5%. but clearly incompatible with the much lower
seroprevalence in suburban (11-6%) and non-metropolitan districts (7-6%).
One interpretation of this, supported by further analysis, was that the
seroprevalence in UK-born women depended on the type of district. There were
additional associations between seroprevalence and both the Jarman Area score
and population density. These findings must be viewed with caution, as the
methodology assumes homogeneity of seroprevalence within country of birth
groups across SE England, and cannot take account of additional factors such as
age-structure, or age at immigration, which could be correlated with Jarman score
and population density.
Geographical analyses based on data from several sources collected at different
times are inherently approximate, and the study should perhaps be regarded as
generating rather than testing hypotheses. Similarly, the estimates of geographical
variation in Table 3 may be less precise than the confidence intervals suggest,
because it is not possible to take these additional sources of uncertainty into
account. In spite of these limitations in the interpretation of the results, this
survey has demonstrated in a large and unbiased population, the lowest antenatal
seroprevalences ever found in the UK. Previous results based on antenatal sera
ranged from 22% in London in the early 1970s [8] to 13% in Glasgow [9]. A
study based on samples sent for routine virological examination in South
Yorkshire between 1988 and 1990 gave an 8-2 % seroprevalenee in 20-30 year olds
[10].
It is likely that the higher seroprevalence among immigrants largely reflects
infection acquired before entry to this country, although the continuation of
culinary traditions after immigration could also play a role. The differences
between UK-born women in inner London and in rural districts, however, remain
to be explained. Studies based on sera which have been stored for up to 30 years
suggest a dramatic fall in age-specific seroprevalence both in England [10] and
Sweden [11]. Some researchers suggest that this is a result of the increased use of
frozen meat, but it is not clear to what extent this could account for geographical
differences in SE England. An alternative explanation for the higher sero-
prevalence in UK-born women in inner London could be the increased contact
with soil contaminated with cat faeces in parks and gardens of the inner city. The
2 to 3-fold geographical differences noted in this study highlight the need for
careful research to determine the relative importance of different routes of
transmission during the childbearing period.
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